Hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2021-03-02
  Clinical Trial Update: Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors [NA]

  Feasibility study of simvastatin in Hodgkin's lymphoma survivors appears terminated with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-02-21
  Clinical Trial Update: Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma [Phase 1, Phase 2]

  Phase 1/2 trial evaluating bendamustine as a bridge to autologous or allogeneic transplant for relapsed/refractory lymphoma has completed wi…

• CLINICAL_TRIALS trial_result · 2021-02-03
  Clinical Trial Update: Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma [Phase 3]

  Phase 3 trial evaluating FDG-P18 PET-guided therapy versus standard therapy in previously untreated Stage I/II Hodgkin lymphoma; current sta…

• CLINICAL_TRIALS trial_result · 2021-01-06
  Clinical Trial Update: Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma [Phase 1, Phase 2]

  A completed Phase 1/2 trial evaluated panobinostat in combination with ICE chemotherapy for relapsed Hodgkin lymphoma, with results posted i…

• CLINICAL_TRIALS trial_result · 2020-12-22
  Clinical Trial Update: Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease. [Phase 2]

  Phase 2 trial update evaluating Brentuximab Vedotin in elderly patients with Hodgkin Lymphoma at first relapse or with primary refractory di…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-12-22
  Clinical Trial Update: Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating chemotherapy guided by PET scan in early-stage Hodgkin lymphoma (Stage I/II) has been terminated; results posted.

• CLINICAL_TRIALS trial_result · 2020-12-17
  Clinical Trial Update: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies [Phase 1, Phase 2]

  A phase 1/2 clinical trial evaluating HCD122 in adults with Non-Hodgkin's or Hodgkin's lymphoma following at least two prior therapies has b…

• CLINICAL_TRIALS trial_result · 2020-12-04
  Clinical Trial Update: CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. [Phase 1, Phase 2]

  A phase 1/2 clinical trial evaluating HSP-CAR30 CAR T-cells targeting CD30 for relapsed/refractory Hodgkin lymphoma and T-cell lymphoma is o…

• CLINICAL_TRIALS trial_result · 2020-11-13
  Clinical Trial Update: HD18 for Advanced Stages in Hodgkins Lymphoma [Phase 3]

  A Phase 3 clinical trial in Hodgkins Lymphoma has completed the study evaluating HD18 for advanced-stage disease.

• CLINICAL_TRIALS trial_result · 2020-11-13
  Clinical Trial Update: GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]

  Phase II open-label study of AFM13 in relapsed or refractory Hodgkin lymphoma has completed recruitment.

• CLINICAL_TRIALS trial_result · 2020-11-04
  Clinical Trial Update: HD16 for Early Stage Hodgkin Lymphoma [Phase 3]

  A Phase 3 trial update for HD16 in early-stage Hodgkin lymphoma is reported, with status not specified.

• CLINICAL_TRIALS trial_result · 2020-09-22
  Clinical Trial Update: Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma [Phase 2]

  Phase 2 trial update on combining nivolumab and brentuximab vedotin in untreated Hodgkin lymphoma in older patients; the study is active-not…

• CLINICAL_TRIALS trial_result · 2020-09-01
  Clinical Trial Update: To Decrease Fatigue With Light Therapy [Phase 3]

  Phase 3 trial investigating light therapy to decrease fatigue in patients with Hodgkin lymphoma and diffuse large B-cell lymphoma has comple…

• CLINICAL_TRIALS trial_result · 2020-08-24
  Clinical Trial Update: Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating Brentuximab Vedotin plus antibody-drug conjugate in non-bulky limited stage Hodgkin Lymphoma has completed with res…

• CLINICAL_TRIALS trial_result · 2020-08-18
  Clinical Trial Update: The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma. [Phase 2]

  Phase 2 trial evaluating chidamide + decitabine + camrelizumab versus decitabine + camrelizumab in anti-PD-1 resistant classical Hodgkin lym…

• CLINICAL_TRIALS trial_result · 2020-08-14
  Clinical Trial Update: Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating adding chidamide to decitabine plus camrelizumab in patients with relapsed/refractory classical Hodgkin lymphoma.

• CLINICAL_TRIALS trial_result · 2020-08-14
  Clinical Trial Update: Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma [Phase 1, Phase 2]

  A phase 1/2 trial evaluating pembrolizumab plus lenalidomide in relapsed Hodgkin and non-Hodgkin lymphoma was terminated with results posted…

• CLINICAL_TRIALS trial_result · 2020-08-12
  Clinical Trial Update: Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 2, Phase 3]

  A phase 2/3 trial is evaluating camrelizumab plus decitabine in patients with relapsed/refractory classical Hodgkin lymphoma who are PD-1 tr…

• CLINICAL_TRIALS trial_result · 2020-08-12
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma [Phase 2]

  Phase 2 clinical trial update evaluating combination chemotherapy for advanced Hodgkin's lymphoma, completed.

• CLINICAL_TRIALS trial_result · 2020-07-21
  Clinical Trial Update: Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) [Phase 2]

  Phase 2 trial evaluating Brentuximab Vedotin as an alternative to autologous stem cell transplantation in relapsed/refractory classical Hodg…

• CLINICAL_TRIALS trial_result · 2020-07-17
  Clinical Trial Update: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]

  Phase 1/2 trial evaluating Brentuximab Vedotin in combination with Bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma. The…

• CLINICAL_TRIALS trial_result · 2020-07-14
  Clinical Trial Update: Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial evaluating autologous peripheral stem cell transplant in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma has comple…

• CLINICAL_TRIALS trial_result · 2020-05-28
  Clinical Trial Update: A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]

  A clinical trial evaluating the safety and efficacy of nivolumab plus bendamustine in relapsed/refractory Hodgkin's lymphoma has completed p…

• CLINICAL_TRIALS trial_result · 2020-05-18
  Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]

  Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-04-21
  Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]

  Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.